Dieser Kaninchen Polyklonal Antikörper erkennt spezifisch ICAM1 in WB und FACS. Er zeigt eine Reaktivität gegenüber Human und wurde in 3+ Publikationen erwähnt.
This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Immunogen
This ICAM1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 488-514 amino acids from the C-terminal region of human ICAM1.
Denkers, de Jong-de Boer, Beelen, Ossenkoppele, Langenhuijsen: "VLA molecule expression may be involved in the release of acute myeloid leukaemic cells from the bone marrow." in: Leukemia research, Vol. 16, Issue 5, pp. 469-74, (1992) (PubMed).
Rössler, Neuchrist, Kitz, Scheiner, Kraft, Lassmann: "Expression of leucocyte adhesion molecules at the human blood-brain barrier (BBB)." in: Journal of neuroscience research, Vol. 31, Issue 2, pp. 365-74, (1992) (PubMed).
Target
ICAM1
(Intercellular Adhesion Molecule 1 (ICAM1))
Andere Bezeichnung
ICAM1
Hintergrund
ICAM1 is a cell surface glycoprotein which is typically expressed on endothelial cells and cells of the immune system. It binds to integrins of type CD11a / CD18, or CD11b / CD18 and is also exploited by Rhinovirus as a receptor.